LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - ARS Pharmaceuticals (NASDAQ: SPRY)

Follow NASDAQ:SPRY Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
07/01/2025
Sell
$1.50
15,000
$23K
544,588
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
07/01/2025
Buy
$1.50
15,000
$23K
25,315
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
07/01/2025
Sell
$16.99
15,000
$255K
10,315
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
06/27/2025
Sell
$18.46
370,074
$6.832M
4.89M
NASDAQ SPRY ARS Pharmaceuticals
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Dadoo Rajeev / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Shah Pratik / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Kelly Michael / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Islam Saqib / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Thompson Peter A. / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
SAUNDERS BRENT L / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
SCHNEIDER PHILLIP M / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
06/25/2025
Buy
$17.26
30,000
$518K
30,000
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
06/18/2025
Sell
$1.50
15,000
$23K
559,588
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
06/18/2025
Buy
$1.50
15,000
$23K
22,696
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
06/18/2025
Sell
$16.00
15,000
$240K
7,696
NASDAQ SPRY ARS Pharmaceuticals
Fitzpatrick Alexander A / officer: Chief Legal Officer
05/20/2025
Sell
$5.58
100,000
$558K
200,000
NASDAQ SPRY ARS Pharmaceuticals
Fitzpatrick Alexander A / officer: Chief Legal Officer
05/20/2025
Buy
$5.58
100,000
$558K
192,582
NASDAQ SPRY ARS Pharmaceuticals
Fitzpatrick Alexander A / officer: Chief Legal Officer
05/20/2025
Sell
$14.10
102,969
$1.452M
89,613
NASDAQ SPRY ARS Pharmaceuticals
SAUNDERS BRENT L / director
05/20/2025
Sell
$1.01
120,000
$121K
470,950
NASDAQ SPRY ARS Pharmaceuticals
SAUNDERS BRENT L / director
05/20/2025
Buy
$1.01
120,000
$121K
120,000
NASDAQ SPRY ARS Pharmaceuticals
SAUNDERS BRENT L / director
05/20/2025
Sell
$14.25
120,000
$1.710M
0
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
05/20/2025
Sell
$1.50
50,000
$75K
752,330
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
05/20/2025
Buy
$1.50
50,000
$75K
57,424
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
05/20/2025
Sell
$14.10
50,000
$705K
7,424

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous